Investors impatient for Alzheimer’s cure

Investors show signs of impatience about drugs that are being tested as a treatment for Alzheimer’s disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.